全文获取类型
收费全文 | 28751篇 |
免费 | 2303篇 |
国内免费 | 682篇 |
专业分类
耳鼻咽喉 | 115篇 |
儿科学 | 1964篇 |
妇产科学 | 182篇 |
基础医学 | 5610篇 |
口腔科学 | 110篇 |
临床医学 | 2844篇 |
内科学 | 5553篇 |
皮肤病学 | 119篇 |
神经病学 | 525篇 |
特种医学 | 352篇 |
外科学 | 966篇 |
综合类 | 5671篇 |
现状与发展 | 3篇 |
预防医学 | 2494篇 |
眼科学 | 32篇 |
药学 | 3373篇 |
31篇 | |
中国医学 | 1722篇 |
肿瘤学 | 70篇 |
出版年
2024年 | 50篇 |
2023年 | 324篇 |
2022年 | 790篇 |
2021年 | 1229篇 |
2020年 | 1148篇 |
2019年 | 850篇 |
2018年 | 853篇 |
2017年 | 936篇 |
2016年 | 1171篇 |
2015年 | 1103篇 |
2014年 | 1980篇 |
2013年 | 3096篇 |
2012年 | 1918篇 |
2011年 | 1979篇 |
2010年 | 1496篇 |
2009年 | 1346篇 |
2008年 | 1270篇 |
2007年 | 1425篇 |
2006年 | 1367篇 |
2005年 | 1179篇 |
2004年 | 1080篇 |
2003年 | 1002篇 |
2002年 | 638篇 |
2001年 | 534篇 |
2000年 | 436篇 |
1999年 | 414篇 |
1998年 | 326篇 |
1997年 | 312篇 |
1996年 | 249篇 |
1995年 | 154篇 |
1994年 | 149篇 |
1993年 | 105篇 |
1992年 | 96篇 |
1991年 | 95篇 |
1990年 | 96篇 |
1989年 | 59篇 |
1988年 | 63篇 |
1987年 | 55篇 |
1986年 | 70篇 |
1985年 | 77篇 |
1984年 | 33篇 |
1983年 | 34篇 |
1982年 | 31篇 |
1981年 | 26篇 |
1980年 | 34篇 |
1979年 | 16篇 |
1978年 | 10篇 |
1977年 | 8篇 |
1976年 | 8篇 |
1975年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
重症肺炎患者中性粒细胞胞吐作用的改变 总被引:3,自引:0,他引:3
目的 研究重症肺炎患者中性粒细胞的功能改变。方法 采用免疫化学法测定 32例重症肺炎患者中性粒细胞胞吐作用和氧化酶反应的变化 ,并与健康对照组比较。结果 重症肺炎患者血液中性粒细胞的基础和PMA刺激的胞吐作用均明显下降 (P <0 .0 1) ;重症肺炎患者的基础和PMA刺激的反应性氧属 (ROS)产生明显增加 ;重症肺炎患者肺部中性粒细胞释放乳铁蛋白、髓过氧化物酶 (MPO)和ROS增加 ,PMA刺激后相似 ;肺炎的严重性与血液中性粒细胞释放乳铁蛋白呈负相关。结论 重症肺炎患者中性粒细胞胞吐作用明显受损 ,与预后相关。 相似文献
52.
Benjamin H. S. Lau Sharon K. Riesen Kim P. Truong Esther W. Lau Peter Rohdewald Ray A. Barreta 《The Journal of asthma》2004,41(8):825-832
A randomized, placebo-controlled, double-blind study involving 60 subjects, aged 6-18 years old, was conducted over a period of 3 months to determine the effect of Pycnogenol® (a proprietary mixture of water-soluble bioflavonoids extracted from French maritime pine) on mild-to-moderate asthma. After baseline evaluation, subjects were randomized into two groups to receive either Pycnogenol® or placebo. Subjects were instructed to record their peak expiratory flow with an Assess® Peak Flow Meter each evening. At the same time, symptoms, daily use of rescue inhalers (albuterol), and any changes in oral medications were also recorded. Urine samples were obtained from the subjects at the end of the run-in period, and at 1-, 2-, and 3-month visits. Urinary leukotriene C4/D4/E4 was measured by an enzyme immunoassay. Compared with subjects taking placebo, the group who took Pycnogenol® had significantly more improvement in pulmonary functions and asthma symptoms. The Pycnogenol® group was able to reduce or discontinue their use of rescue inhalers more often than the placebo group. There was also a significant reduction of urinary leukotrienes in the Pycnogenol® group. The results of this study demonstrate the efficacy of Pycnogenol® as an adjunct in the management of mild-to-moderate childhood asthma. 相似文献
53.
Xiao-Mei Mai Per-Olof Gäddlin Lennart Nilsson Ingemar Leijon 《Pediatric allergy and immunology》2005,16(5):380-385
Early catch-up growth and subsequent overweight are suggested to be associated with later cardiovascular diseases and later type II diabetes. However, the impact of early catch-up growth and childhood overweight on the development of asthma has been less studied, particularly in children born with very low birth weight (VLBW). A birth cohort of 74 VLBW children (birth weight < or = 1500 g) was followed from birth and investigated on asthma at 12 yr of age. Early rapid weight gain was in one way defined as an increase of weight > or =1 standard deviation score (SDS) at 6 months of corrected postnatal age. Current overweight was defined by body mass index (BMI) exceeding 21.2 and 21.7 kg/m(2), respectively, for boys and girls at 12 yr of age. Current asthma was diagnosed by a pediatrician, according to asthma ever in combination with a positive response to hypertonic saline bronchial provocation test and/or wheeze at physical examination at 12 yr old. Being overweight at 12 yr of age was associated with an increased risk for current asthma in the VLBW children [crude odds ratio (OR): 5.5, 95% confidence interval (CI): 1.3-22.2]. After adjustment for early weight gain and neonatal risk, the OR of overweight increased nearly three times (adjusted OR: 15.3, 95% CI: 2.5-90.6). Early rapid weight gain seemed to be inversely associated with current asthma (adjusted OR: 0.49 for an increase of weight equal to 1 SDS, 95% CI: 0.23-1.02, p = 0.06). In addition, early rapid weight gain was inversely associated with the magnitude of bronchial responsiveness at 12 yr (coefficient -1.15, p < 0.01). There was a strong and positive association between overweight and asthma at 12 yr of age in the VLBW children. This strong association had been reduced by early rapid weight gain, possibly via the reduction of bronchial responsiveness. 相似文献
54.
C. Grüber S. Illi A. Plieth C. Sommerfeld U. Wahn 《Clinical and experimental allergy》2002,32(4):526-531
BACKGROUND: Turkish children have been found to suffer less from atopic diseases than their German peers. The underlying causes are unknown. OBJECTIVE: To evaluate rates of sensitization and atopic disease among children in Germany with German or Turkish ethnicity and different degrees of cultural adaptation. METHODS: This was a cross-sectional study. The setting was screening for school eligibility in an inner-city district of Berlin/Germany. The participants were preschool children born in Germany with double German or double Turkish parental citizenship. Cultural adaptation of Turkish children was assessed by the language parents used to communicate with their child: only Turkish (n = 60, group A); Turkish and German (n = 269, group B); and only German (n = 103, group C). Group D contained children from German parents (n = 383). The main outcome measures were specific sensitization to common aeroallergens (CAP-System, Pharmacia Phadiatop >or= 0.35 kU/L), and lifetime and 1-year prevalences of allergic disease symptoms (ISAAC questionnaire in German and Turkish, Mantel-Haenszel test for trend). RESULTS: Sensitization rates for groups A, B, C and D were 8.0%, 6.8%, 18.9% and 18.3%, respectively (P = 0.004). The corresponding prevalence rates for wheeze ever were 6.7%, 9.3%, 12.6% and 21.3% (P < 0.001), wheeze in the past year 3.3%, 3.7%, 9.7% and 10.2% (P = 0.001), itchy rash ever 3.3%, 6.3%, 8.7% and 13.7% (P < 0.001), itchy rash in the past year 1.7%, 3.7%, 4.9% and 9.5% (P < 0.001), respectively. No significant differences were found for hay fever symptoms. CONCLUSIONS: Higher cultural adaptation is correlated with higher rates of allergic sensitization and disease among children of Turkish origin living in Berlin. This correlation suggests that environmental rather than genetic differences are responsible for the differences observed. 相似文献
55.
氧化苦参碱对哮喘小鼠抗炎作用的研究 总被引:23,自引:0,他引:23
目的:探讨氧化苦参碱治疗哮喘的抗炎作用机制及其对白细胞介素-4(IL-4mRNA)表达的影响。方法:建立小鼠哮喘模型,观察氧化苦参碱对哮喘小鼠支气管肺泡灌洗液中炎性细胞、肺组织病理的改变;应用半定量反转录-聚合酶链反应检测肺组织IL-4mRNA表达的变化。结果:氧化苦参碱可显著减轻哮喘小鼠气道及肺组织中哮酸性细胞的浸润,显著抑制哮喘小鼠肺组织中IL-4mRNA的表达水平。结论:氧化苦参碱对哮喘小鼠有明显的抗气道变应性炎症及抑制IL-4mRNA表达的作用。 相似文献
56.
Nhân Pham-Thi Pierre Scheinmann Riad Fadel Anne Combebias Claude Andre the Study Group 《Pediatric allergy and immunology》2007,18(1):47-57
Although several studies have demonstrated the efficacy of subcutaneous immunotherapy in allergic asthma, few have shown the same benefit using sublingual immunotherapy (SLIT) in asthmatic patients. This study was conducted to assess the efficacy of house dust mite (HDM) SLIT in addition to allergen avoidance and standard pharmacologic treatment. A double-blind, placebo-controlled trial was performed in 111 children (aged 5-15 yr) with HDM-induced mild-to-moderate asthma. After a 4-week baseline phase, patients were randomly assigned to receive SLIT with tablets of HDM extract (n = 55) or placebo (n = 56) for 18 months. Pharmacologic treatment was adjusted every 3 months following a step-down approach. Asthma symptom scores, reduction in use of inhaled corticosteroids and inhaled beta(2)-agonists, rhinitis symptoms, lung function tests, skin sensitivity to HDM, dust mite-specific immunoglobulin (Ig) E and IgG(4), and quality of life (QoL) were assessed during the study. After 18 months of treatment, diurnal and nocturnal asthma symptoms scores did not show significant differences between SLIT and placebo groups. Inhaled corticosteroids and inhaled beta(2)-agonists use was reduced in both groups without significant differences between groups. There were no significant differences in lung function (forced expiratory volume in 1 s and peak flow rate variations) between groups. Rhinitis symptom score decreased in both groups, with no difference between the two groups. The severity dimension of QoL was significantly improved in the SLIT group (age 6-12 yr). SLIT induced a significant reduction of skin sensitivity to HDM (p < 0.01) and a significant increase in HDM-specific IgE and IgG(4) antibodies (p < 0.001) in the SLIT group compared with the placebo group. SLIT was well tolerated with mild/moderate local adverse events. No severe systemic reactions were reported. This study indicates that, when mild-moderate asthmatic children are optimally controlled by pharmacologic treatment and HDM avoidance, SLIT does not provide additional benefit, despite a significant reduction in allergic response to HDM. Under such conditions, only a complete, but ethically unfeasible, discontinuation of inhaled corticosteroid would have demonstrated a possible benefit of SLIT. 相似文献
57.
N. E. McCarthy H. A. Jones N. A. Marks R. J. Shiner P. W. Ind H. O. Al-Hassi N. R. English C. M. Murray J. R. Lambert S. C. Knight A. J. Stagg 《Clinical and experimental allergy》2007,37(1):72-82
Background Dendritic cells (DC) mediate inflammation in rodent models of allergic airway disease, but the role played by human respiratory‐tract DC (hRTDC) in atopic asthma remains poorly defined. Recent data suggest that CD1 antigen presentation by hRTDC may contribute to asthma pathogenesis. Objective To investigate the influence of hRTDC on the balance between atopy and allergic asthma in human subjects and to determine whether CD1 expression by hRTDC is modulated during asthmatic inflammation. Methods Sputum cells were induced from steroid‐naïve, allergen‐challenged and allergen‐naïve subjects (atopic asthmatics, atopic non‐asthmatics and non‐atopic controls). hRTDC were identified using monoclonal antibody labelling and analysis by flow cytometry. Results hRTDC stained HLA‐DR+ (negative for markers of other cell lineages) were predominantly myeloid and comprised ∼0.5% of viable sputum cells. Sputum cells were potent stimulators of allogeneic CD4+ naïve T cells and enrichment/depletion experiments correlated stimulatory potency with DC numbers. Sputum contained cells that exhibited typical dendritic morphology when analysed by electron microscopy. Myeloid hRTDC were endocytically active, but uptake of FITC‐dextran was enhanced in cells from asthmatics (P<0.001). Despite their increased endocytic capacity, asthmatic myeloid hRTDC appeared mature and expressed increased levels of maturation markers (P<0.05–P<0.001), CD1c, CD1d and langerin (P<0.05). CD1c expression by asthmatic myeloid hRTDC was enhanced upon in vivo allergen challenge (three to ninefold within 24 h; P<0.05). CD11c−CD123high hRTDC were only detected in asthmatic sputum and were increased in number following allergen challenge. Conclusion Despite limited cell numbers, it proved possible to analyse human RTDC in induced sputum, providing evidence that increased antigen uptake and enhanced CD1 presentation by activated hRTDC may contribute to allergic airway disease. CD1 presentation by hRTDC in atopic asthma may therefore constitute a novel target for future intervention strategies. 相似文献
58.
重型颅脑损伤后凝血功能变化的研究 总被引:2,自引:1,他引:1
目的研究重型颅脑损伤后凝血功能的变化及临床意义。方法对本院2005年3月至2006年2月收治的26例重型单纯性颅脑损伤患者(GCS≤8分)进行前瞻性研究,监测其入院当时、入院第2天、第3天及第7天的部分凝血活酶时间(APTT),凝血酶原时间(PT),纤维蛋白原(FIB)及凝血时间(TT)的变化。并检测14例单纯头部外伤患者在入院时的APTT、PT、FIB和TT值。结果APTT在入院3天明显升高。1周后仍未达到正常(P〈0.05);PT在入院当天即升高(P〈0.05),1周左右逐步恢复正常;FIB在入院当天即升高,第3天下降(P〈0.05),1周左右逐步恢复正常。有3例按照DIC诊断标准诊断为DIC,结果在观察期间均死亡。结论重型颅脑损伤后可发生凝血功能异常,且外凝性凝血途径的启动早于内源性凝血途径。伤后早期即可发生高凝状态,至第3天左右向低凝状态转变,1周左右恢复正常。 相似文献
59.
Judith D. DePue Elizabeth L. McQuaid Daphne Koinis-Mitchell Christopher Camillo Anthony Alario Robert B. Klein 《The Journal of asthma》2007,44(6):449-453
Over 3 years, 972 families participated in an after-school asthma program at their child's school. Parents and children attended concurrent 21/2 -hour workshops. Parents were 74% Latino; 45% non-English speaking, with 77% of children on Medicaid. Asthma symptoms were significantly reduced, from multiple times per week to less than once per week on average. Oral steroid use decreased to one third of baseline use. Hospital days decreased from 11% to 2%; emergency visits decreased 35% to 4%; and school days missed decreased 48% to 20%. This program has now become sustainable with both private and Medicaid insurance coverage. 相似文献
60.
Kim Mudd Mary Elizabeth Bollinger Van Doren Hsu Michele Donithan Arlene Butz 《The Journal of asthma》2006,43(8):597-600
Background. Medication adherence impacts healthcare utilization. Pharmacy records are useful to establish fill patterns. Objective. Use pharmacy records to establish medication patterns fill patterns for comparison to healthcare utilization. Methods. Pharmacy records of 175 children with persistent asthma were collected and compared to healthcare utilization. Results. Majority of subjects had significant healthcare utilization, low numbers of rescue medications, and poor controller medication fill rates. Those with more rescue medications had more healthcare utilization and more controller medications. Conclusions. Pharmacy fill patterns demonstrate few rescue and/or controller medication fills. Those with more rescue medications reported increased healthcare utilization despite controller medications. 相似文献